Johnson & Johnson has filed suit in federal court against Abbott Laboratories and two medical device manufacturers, seeking at least $5.5 billion for alleged tortious interference and breach of a merger agreement.
The New Brunswick, N.J.-based health care company charges that a planned $24.2 billion acquisition of Guidant Corp. of Indianapolis was scotched in early January after Guidant leaked confidential information to another manufacturer, Boston Scientific Corp., which ultimately bought Guidant for $27 billion.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
